Condition: Colitis Ulcerative · Ulcerative Colitis · Sponsor: Merck Sharp & Dohme LLC
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Score at Week 12.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Clinnova Research ( Site 1042) | Anaheim, California, United States | Recruiting |
| Peak Gastroenterology Associates ( Site 1052) | Colorado Springs, Colorado, United States | Recruiting |
| South Denver Gastroenterology, PC ( Site 1068) | Englewood, Colorado, United States | Recruiting |
| Nature Coast Clinical Research ( Site 1045) | Inverness, Florida, United States | Recruiting |
| Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072) | Miami, Florida, United States | Recruiting |
| Gastroenterology Associates of Central Georgia ( Site 1060) | Macon, Georgia, United States | Recruiting |
| University of Kansas Medical Center ( Site 1077) | Kansas City, Kansas, United States | Recruiting |
| Tulane University School of Medicine ( Site 1073) | New Orleans, Louisiana, United States | Recruiting |
| BVL Research - Kansas ( Site 1054) | Liberty, Missouri, United States | Recruiting |
| Radboudumc ( Site 1650) | Nijmegen, Gelderland, Netherlands | Recruiting |
| EB Group Sp. Z o.o. Centrum Zdrowia MDM ( Site 1449) | Warsaw, Masovian Voivodeship, Poland | Recruiting |
| Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś ( Site 1448) | Warsaw, Masovian Voivodeship, Poland | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07463183